{"filing":{"accession_number":"0001213900-26-085514","cik":"0001139685","ticker":"AIDX","company_name":"20/20 Biolabs, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"ea0300726-8k_2020bio.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026085514/ea0300726-8k_2020bio.htm"},"events":[{"id":24786,"run_id":22476,"accession_number":"0001213900-26-085514","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This Item 7.01 disclosure furnishes investor presentation materials for an August 5, 2026 webinar. The presentation covers operational and commercial progress including Q2 2026 sales updates (\"best quarterly cancer testing revenue to date\"), new customer wins (29 new accounts, Maryland firefighter program, Vermont expansion), a new Giant Food pilot for OneTest for Longevity, and CEO's East Asia trip for commercial and M\u0026A exploration. While the filing explicitly disclaims that the furnishing is required by Regulation FD or that materials contain material investor information not otherwise publicly available, the substantive content—revenue milestones, customer acquisitions, product pilots, and strategic expansion—constitutes material operational and commercial developments that would affect a reasonable investor's assessment of the company's business trajectory and growth prospects.","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25458,"accession_number":"0001213900-26-085514","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This Item 7.01 disclosure furnishes investor presentation materials for an August 5, 2026 webinar. The presentation covers operational and commercial progress including Q2 2026 sales updates (\"best quarterly cancer testing revenue to date\"), new customer wins (29 new accounts, Maryland firefighter program, Vermont expansion), a new Giant Food pilot for OneTest for Longevity, and CEO's East Asia trip for commercial and M\u0026A exploration. While the filing explicitly disclaims that the furnishing is required by Regulation FD or that materials contain material investor information not otherwise publicly available, the substantive content—revenue milestones, customer acquisitions, product pilots, and strategic expansion—constitutes material operational and commercial developments that would affect a reasonable investor's assessment of the company's business trajectory and growth prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:21:38.598820+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25458,"accession_number":"0001213900-26-085514","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This Item 7.01 disclosure furnishes investor presentation materials for an August 5, 2026 webinar. The presentation covers operational and commercial progress including Q2 2026 sales updates (\"best quarterly cancer testing revenue to date\"), new customer wins (29 new accounts, Maryland firefighter program, Vermont expansion), a new Giant Food pilot for OneTest for Longevity, and CEO's East Asia trip for commercial and M\u0026A exploration. While the filing explicitly disclaims that the furnishing is required by Regulation FD or that materials contain material investor information not otherwise publicly available, the substantive content—revenue milestones, customer acquisitions, product pilots, and strategic expansion—constitutes material operational and commercial developments that would affect a reasonable investor's assessment of the company's business trajectory and growth prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:21:38.598820+00:00","company_name":"20/20 Biolabs, Inc.","ticker":"AIDX","filing_date":"2026-08-05"}]}